Mivigilance is a leading global provider of specialized compliance, pharmacovigilance, and medical information services, serving pharmaceutical, biotech, medical device companies, CROs, hospitals, and patients. The company stands out through its fully integrated 24/7/365 contact centers and its commitment to delivering cost-effective, innovative, and high-quality solutions across the entire drug life cycle.
With an unrivalled team of experts, Mivigilance adopts a dynamic and agile approach to solving complex challenges in the medical and regulatory landscape. The company emphasizes bespoke solutions, continuous quality improvement, and the integration of advanced technologies to enhance patient safety and support drug development. Its core values include quality, innovation, collaborative partnership, and adaptability to the ever-changing pharmaceutical environment.
Services Offered
- Pharmacovigilance
- Medical Information Services
- Medical Writing
- Training Programs
- Quality Consulting
- GXP Auditing (GVP, GCP, GCLP)
- Gap Analysis
- Inspection Readiness Support
- Adverse Event Reporting
- Product Quality Complaint Handling
- Crisis Management and Product Recalls
- Compassionate Use and Expanded Access Program Support
- Clinical Trial Support
- Risk Evaluation and Mitigation Strategies (REMS)
- Medical Conference Support
- Content Creation (FAQs, Standard Response Letters)
- Omnichannel Communication Support (phone, email, chat, video, SMS, AI)
Mivigilance supports a wide range of therapeutic areas, including infectious diseases, vaccines, oncology, cardiovascular, metabolic, respiratory, and rare diseases. The company operates globally and maintains a robust quality management system designed for anytime inspection readiness, ensuring the highest standards in all services provided.
